🔗 Share this article

This year's Nobel Prize in medical science was granted for revolutionary findings that illuminate how the immune system attacks harmful pathogens while sparing the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

Their work uncovered unique "security guards" within the defense system that remove malfunctioning immune cells capable of attacking the body.

These discoveries are now paving the way for new treatments for autoimmune diseases and cancer.

The laureates will divide a monetary award worth 11m Swedish kronor.

Decisive Findings

"Their work has been essential for comprehending how the body's defenses functions and the reason we do not all suffer from serious autoimmune diseases," commented the chair of the award panel.

This trio's studies explain a fundamental mystery: How does the defense system defend us from numerous infections while leaving our own tissues unharmed?

Our body's protection system uses immune cells that scan for signs of infection, including pathogens and bacteria it has never encountered.

Such defenders utilize sensors—known as recognition units—that are produced randomly in a vast number of combinations.

This provides the immune system the capacity to fight a broad range of threats, but the unpredictability of the mechanism unavoidably creates white blood cells that may target the body.

Security Guards of the Immune System

Researchers previously understood that a portion of these problematic white blood cells were destroyed in the thymus—the site where white blood cells mature.

This year's Nobel Prize honors the discovery of T-reg cells—described as the body's "peacekeepers"—which patrol the system to disarm any defenders that assault the body's own tissues.

It is known that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

The Nobel panel stated, "These discoveries have laid the foundation for a new field of investigation and accelerated the creation of innovative treatments, for instance for cancer and immune disorders."

In cancer, T-regs prevent the system from attacking the tumor, so research are aimed at reducing their numbers.

For self-attack disorders, trials are exploring boosting T-reg cells so the body is not under attack. A comparable approach could also be useful in reducing the risks of organ transplant rejection.

Innovative Experiments

Professor Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland extracted, leading to self-attack conditions.

He showed that introducing immune cells from other animals could stop the illness—suggesting there was a mechanism for blocking immune cells from attacking the body.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were investigating an inherited autoimmune disease in mice and humans that led to the identification of a gene critical for the way regulatory T-cells operate.

"The pioneering work has revealed how the immune system is kept in check by T-reg cells, stopping it from accidentally attacking the body's own tissues," commented a leading physiology specialist.

"This research is a remarkable illustration of how fundamental physiological research can have far-reaching implications for human health."